Several studies have demonstrated that UCA1 promotes cell proliferation and EMT in osteosarcoma (38), glioma (81) and papillary thyroid carcinoma (82) by activating the Wnt/β-catenin signaling pathway. Here, UCA1 is linked to central nervous system cancer.